Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 540

3.

Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Latin America: results from the PROTEKT surveillance study (1999-2000).

Mendes C, Marin ME, Quiñones F, Sifuentes-Osornio J, Siller CC, Castanheira M, Zoccoli CM, López H, Súcari A, Rossi F, Angulo GB, Segura AJ, Starling C, Mimica I, Felmingham D.

Braz J Infect Dis. 2003 Feb;7(1):44-61.

4.
7.

Comparative activity of telithromycin against typical community-acquired respiratory pathogens.

Buxbaum A, Forsthuber S, Graninger W, Georgopoulos A.

J Antimicrob Chemother. 2003 Sep;52(3):371-4. Epub 2003 Jul 29.

8.

Global surveillance through PROTEKT: the first year.

Grüneberg RN.

J Chemother. 2002 Jul;14 Suppl 3:9-16.

PMID:
12418556
10.
13.
17.
18.

The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents.

Jacobs MR, Felmingham D, Appelbaum PC, Grüneberg RN; Alexander Project Group.

J Antimicrob Chemother. 2003 Aug;52(2):229-46. Epub 2003 Jul 15.

19.

Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998.

Thornsberry C, Jones ME, Hickey ML, Mauriz Y, Kahn J, Sahm DF.

J Antimicrob Chemother. 1999 Dec;44(6):749-59.

20.

In vitro activity of ABT-773, telithromycin and eight other antimicrobials against erythromycin-resistant Streptococcus pneumoniae respiratory isolates of children.

Johnson CN, Benjamin WH Jr, Gray BM, Crain MC, Edwards KM, Waites KB.

Int J Antimicrob Agents. 2001 Dec;18(6):531-5.

PMID:
11738340
Items per page

Supplemental Content

Write to the Help Desk